IJR News — today's news from every sideDr. David Crean Book Guides Biopharma Leaders on Commercialization — 10hA new book, Dual Fluency: Bridging Science, Capital, and Governance in Life Sciences by Dr. David H. Crean, offers a practical blueprint for biopharma to move from discovery to commercialization by focusing on three core translations—Data to Capital, Discovery to Deal, and Bench to Boardroom—along with Capital Stack Optimization. Aimed at scientist-founders, pre-commercial CEOs, BD executives, and investors, the work promises actionable risk-reduction insights and will be available on Amazon and major bookstores through Cardiff Advisory LLC.
Jared Kim This book seems helpful for scientist founders who struggle turning research into actual funding and governance plans.Rachel Meyers Preston's home form has been dire, if Blackburn nick it there it could get really tense on the terraces. 
